# A Double-blind, Randomized, Controlled Trial of Quetiapine Versus Haloperidol for the Treatment of Delirium

> **NCT00954603** · PHASE3 · TERMINATED · sponsor: **Chiang Mai University** · enrollment: 52 (actual)

## Conditions studied

- Delirium

## Interventions

- **DRUG:** quetiapine
- **DRUG:** haloperidol

## Key facts

- **NCT ID:** NCT00954603
- **Lead sponsor:** Chiang Mai University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-06
- **Primary completion:** 2011-04
- **Final completion:** 2012-07
- **Target enrollment:** 52 (ACTUAL)
- **Why stopped:** few delirious patients were enrolled.
- **Last updated:** 2011-06-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00954603

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00954603, "A Double-blind, Randomized, Controlled Trial of Quetiapine Versus Haloperidol for the Treatment of Delirium". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00954603. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*